Literature DB >> 19359864

Bone marrow: orchestrated cells, cytokines, and growth factors for bone regeneration.

Muna Soltan1, Dennis Smiler, Jennifer H Choi.   

Abstract

Bone regeneration requires an orchestrated interaction between various cells and other biological components. The synthesis of bone matrix with the release of cellular cytokines and growth factors facilitates and regulates cell growth. This leads to the maturation of bone that can support functional implants. Bone-marrow aspirate is a rich source of cells, cytokines, and growth factors needed for bone formation. Harvesting the marrow from the anterior iliac crest is a simple, safe, and cost-effective procedure. Mixing it with a resorbable scaffold and transplanting it to a site can predictably enhance bone regeneration. This article explores the anatomy of the bone marrow and describes the necessary elements for successful bone grafts, such as cells, bone matrix, and cellular regulators (both soluble and insoluble).

Mesh:

Substances:

Year:  2009        PMID: 19359864     DOI: 10.1097/ID.0b013e3181990e75

Source DB:  PubMed          Journal:  Implant Dent        ISSN: 1056-6163            Impact factor:   2.454


  10 in total

1.  Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan-Ho Park; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

2.  Accelerated osteoblast mineralization on a conductive substrate by multiple electrical stimulation.

Authors:  Shiyun Meng; Ze Zhang; Mahmoud Rouabhia
Journal:  J Bone Miner Metab       Date:  2011-02-17       Impact factor: 2.626

3.  Prognostic significance of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis.

Authors:  Hiroshi Fukushima; Takahiro Hozumi; Takahiro Goto; Keiji Nihei; Katsuyuki Karasawa; Yasukazu Nakanishi; Madoka Kataoka; Ken-Ichi Tobisu; Fumitaka Koga
Journal:  Clin Exp Metastasis       Date:  2016-06-17       Impact factor: 5.150

4.  Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model.

Authors:  Fanglong Song; Jilei Tang; Rui Geng; Hansheng Hu; Chunhui Zhu; Weiding Cui; Weimin Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 5.  A biological global positioning system: considerations for tracking stem cell behaviors in the whole body.

Authors:  Shengwen Calvin Li; Lisa May Ling Tachiki; Jane Luo; Brent A Dethlefs; Zhongping Chen; William G Loudon
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

6.  Synergistic enhancement of ectopic bone formation by supplementation of freshly isolated marrow cells with purified MSC in collagen-chitosan hydrogel microbeads.

Authors:  Joel K Wise; Andrea I Alford; Steven A Goldstein; Jan P Stegemann
Journal:  Connect Tissue Res       Date:  2015-09-04       Impact factor: 3.417

7.  Comparison of uncultured marrow mononuclear cells and culture-expanded mesenchymal stem cells in 3D collagen-chitosan microbeads for orthopedic tissue engineering.

Authors:  Joel K Wise; Andrea I Alford; Steven A Goldstein; Jan P Stegemann
Journal:  Tissue Eng Part A       Date:  2013-09-26       Impact factor: 3.845

Review 8.  Use of stem cells in bone regeneration in cleft palate patients: review and recommendations.

Authors:  Mohammad Amin Amiri; Fatemeh Lavaee; Hossein Danesteh
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2022-04-30

9.  Autologous bone marrow clot as an alternative to autograft for bone defect healing.

Authors:  Z X H Lim; B Rai; T C Tan; A K Ramruttun; J H Hui; V Nurcombe; S H Teoh; S M Cool
Journal:  Bone Joint Res       Date:  2019-04-02       Impact factor: 5.853

10.  In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects.

Authors:  Tongmeng Jiang; Guojie Xu; Qiuyan Wang; Lihui Yang; Li Zheng; Jinmin Zhao; Xingdong Zhang
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.